Primary Site >> Esophagus Cancer
Gene >> TP53
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Frequent mutation of the p53 gene in human esophageal cancer. PMID: 2263646 |
Ref: Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. PMID: 1855226 Ref: p53 gene mutations in Barrett's epithelium and esophageal cancer. PMID: 1868473 Ref: p53 mutations in human cancers. PMID: 1905840 Ref: Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. PMID: 1923503 Ref: p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases. PMID: 1933850 Ref: Oncogene activation in esophageal cancer. PMID: 1943188 Ref: Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction. PMID: 2052580 |
Ref: Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. PMID: 1324797 Ref: p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. PMID: 1347252 Ref: Frequent expression of the tumor antigen CAK1 in squamous-cell carcinomas. PMID: 1351045 Ref: Expression of p53 in human esophageal carcinoma: an immunohistochemical study with correlation to proliferating cell nuclear antigen expression. PMID: 1358781 Ref: p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. PMID: 1394236 Ref: [Overexpression of p53 protein in human spontaneous esophageal carcinoma and fetal esophageal carcinoma induced by N-methyl-N-benzylnitrosamine (NMBzA)]. PMID: 1396069 Ref: Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. PMID: 1423299 Ref: Absence of genomes of DNA tumor viruses and expression of oncogenes and growth factors in two esophageal carcinoma cell lines of Chinese origin. PMID: 1473373 Ref: Sensitive detection of p53 gene mutations in esophageal endoscopic biopsy specimens by cell sorting combined with polymerase chain reaction single-strand conformation polymorphism analysis. PMID: 1483940 Ref: In situ hybridization and immunohistochemistry of p53 tumor suppressor gene in human esophageal carcinoma. PMID: 1519662 Ref: p53 gene mutations in esophageal cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis. PMID: 1644659 Ref: Barretts carcinoma in a 25-year-old man with point mutation of the p53 tumor suppressor gene. PMID: 21584541 |
Ref: [Metastasis related genes and malignancy in human esophageal, gastric and colorectal cancers]. PMID: 8094950 Ref: Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomas. PMID: 8280379 Ref: Prognostic significance of human papillomavirus genomes (type-16, -18) and aberrant expression of p53 protein in human esophageal cancer. PMID: 8387463 Ref: Loss of heterozygosity of p53 in oral cancers demonstrated by the polymerase chain reaction. PMID: 8443743 Ref: Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. PMID: 8467496 Ref: Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. PMID: 8467510 Ref: Molecular and cellular features of esophageal cancer cells. PMID: 8509434 Ref: P53 tumor-suppressor gene and cyclic adenosine-monophosphate in breast and esophageal cancer are regulated through high-concentration of epidermal growth-factor. PMID: 21573446 |
Ref: Molecular approach to rapid assessment of p53 tumor suppressor mutations in esophageal tumors from stained histological slides. PMID: 7520333 Ref: Allelotype study of esophageal carcinoma. PMID: 7522040 Ref: Esophageal cancer. PMID: 7533069 Ref: [Alterations of oncogenes in human fetal esophageal epithelium induced by N-methylbenzylnitrosamine (NMBzA)]. PMID: 7720492 Ref: p53 immunolocalization in cytology specimens: a study in human esophageal carcinoma. PMID: 7813357 Ref: [Barrett esophagus. Current situation of the risk and surveillance policy]. PMID: 7899314 Ref: p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study. PMID: 7915093 Ref: p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. PMID: 7922972 Ref: The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors. PMID: 7927320 Ref: [Mutation of p53 gene in human cancers of the esophagus and gastric cardia]. PMID: 7956692 Ref: High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis. PMID: 7982172 Ref: [The multiple tumor suppressor genes in human esophageal cancer]. PMID: 7994660 Ref: p53 immunoreactivity in carcinosarcoma of the esophagus. PMID: 8007679 Ref: p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. PMID: 8044781 Ref: A unique p53 intragenic deletion flanked by short direct repeats results in loss of mRNA expression in a human esophageal carcinoma. PMID: 8055646 Ref: p53 and ras gene expression in human esophageal cancer and Barrett's epithelium: a prospective study. PMID: 8076380 Ref: Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines. PMID: 8093026 Ref: Relationship between H-ras p21 product and p53 protein or high-risk human papillomaviruses in esophageal cancer from Kochi, Japan. PMID: 8147387 Ref: Allelotype analysis of esophageal squamous cell carcinoma. PMID: 8187088 Ref: Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer. PMID: 8311140 Ref: P53 expression in esophageal dysplasia - a possible biomarker for carcinogenesis of esophageal squamous-cell carcinoma. PMID: 21567020 Ref: High-concentration of epidermal growth-factor induces apoptosis in breast and esophageal cancer-cells transplanted into nude-mice. PMID: 21607490 |
Ref: p53 overexpression in the multistep process of esophageal carcinogenesis. PMID: 7503363 Ref: Expression of p53 protein related to human papillomavirus and DNA ploidy in superficial esophageal carcinoma. PMID: 7549269 Ref: [Correlation studies on the alterations of multiple tumor suppressor genes in human esophageal cancer and in human and monkey esophageal epithelial cells treated with N-methyl-N-benzyl nitrosamine]. PMID: 7587888 Ref: [Multivariate analysis of the prognostic and predictive factors of response to concomitant radiochemotherapy in epidermoid cancers of the esophagus. Value of immunodetection of protein p53]. PMID: 7589997 Ref: Prognostic value of DNA index, S-phase fraction and p53 protein accumulation after surgical resection of esophageal squamous-cell carcinomas in Thailand. PMID: 7591236 Ref: [Analysis of p53 expression and DNA ploidy pattern in esophageal cancer]. PMID: 7611771 Ref: [Multiple tumor suppressor genes in esophageal carcinoma induced in human fetus esophageal epithelium by NMBzA]. PMID: 7656818 Ref: The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents. PMID: 7665247 Ref: Prognostic value of p53 protein in esophageal adenocarcinoma. PMID: 7666667 Ref: p53 mutations in esophageal tumors from high-incidence areas of China. PMID: 7768632 Ref: [Effect of NMBzA on the oncogene and multiple tumor suppressor genes in monkey esophageal epithelium]. PMID: 7781121 Ref: Somatic mutations detected by mini- and microsatellite DNA markers reveal clonal intratumor heterogeneity in gastrointestinal cancers. PMID: 7796414 Ref: [Postoperative prognostic factors for carcinoma of the thoracic esophagus]. PMID: 7887653 Ref: Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis. PMID: 7889467 Ref: High frequency of Ki-ras amplification and p53 gene mutations in adenocarcinomas of the human esophagus. PMID: 8519418 Ref: [Reevaluation of precancerous lesion of squamous cell carcinoma]. PMID: 8607612 Ref: [Correlation between p53 nuclear protein accumulation and mutations of the p53 gene in human esophageal cancer from linxian]. PMID: 8697989 Ref: Variation of p53 mutational spectra between carcinoma of the upper and lower respiratory tract. PMID: 9816043 Ref: New cancer strategy - apoptosis based therapy by growth-factors (review). PMID: 21597680 |
Ref: Basaloid-squamous carcinoma of the esophagus. A clinicopathologic, DNA ploidy, and immunohistochemical study of seven cases. PMID: 8604812 Ref: p53 protein accumulation and gene mutations in multifocal esophageal precancerous lesions from symptom free subjects in a high incidence area for esophageal carcinoma in Henan, China. PMID: 8608498 Ref: What is the earliest malignant lesion in the esophagus? PMID: 8608552 Ref: Association of p53 protein expression with responses and survival of patients with locally advanced esophageal carcinoma treated with chemoradiotherapy. PMID: 8609696 Ref: DNA ploidy, P53 expression, and cellular proliferation in normal epithelium and squamous dysplasia of non-cancerous and cancerous human oesophagi. PMID: 8615609 Ref: Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. PMID: 8682592 Ref: [Prognostic factors for esophageal cancer--from the viewpoint of molecular biology]. PMID: 8687232 Ref: p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China. PMID: 8722219 Ref: [Expression of p53 in human esophageal carcinoma and pre-malignant lesions in the esophagus]. PMID: 8732116 Ref: The molecular biology of esophageal carcinoma. PMID: 8893331 Ref: Prognostic significance of the p53 mutation in esophageal cancer. PMID: 8895666 Ref: Molecular-pathological analysis of a patient with three synchronous squamous cell carcinomas in the aerodigestive tract. PMID: 8895679 Ref: Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors. PMID: 8895744 Ref: Prognostic value of p53 protein expression in squamous cell carcinoma of the esophagus. PMID: 8907205 Ref: [Genetic events during development of esophageal squamous cell carcinoma]. PMID: 8920674 Ref: Isolation of a novel GPI-anchored gene specifically regulated by p53; correlation between its expression and anti-cancer drug sensitivity. PMID: 8934543 Ref: [Overexpression of P53 and its risk factors in esophageal cancer in urban areas of Xian]. PMID: 9275548 |
Ref: p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations. PMID: 9028350 Ref: Expression of p53 protein in glandular differentiation admixed with squamous cell carcinoma of the esophagus. PMID: 9058139 Ref: p53 overexpression and human papillomavirus (HPV) infection in oesophageal squamous cell carcinomas derived from a high-incidence area in China. PMID: 9066606 Ref: Inactivation of the p53 protein in cell lines derived from human esophageal cancers. PMID: 9096669 Ref: p53 alterations but no human papillomavirus infection in preinvasive and advanced squamous esophageal cancer in Italy. PMID: 9138659 Ref: [Detection of human papilloma virus DNA and expression of p53 protein in patients with head and neck cancer]. PMID: 9184031 Ref: Presence of human papillomavirus in esophageal squamous cell carcinomas of Hong Kong Chinese and its relationship with p53 gene mutation. PMID: 9190999 Ref: Prevalence of p53 mutations and protein expression in esophageal cancers in southern Thailand. PMID: 9212217 Ref: [Findings of genetic changes in small intestinal carcinomas]. PMID: 9263525 Ref: [Surgical treatment and research of esophageal cancer in the past and the present era in our department--for the view point of the future]. PMID: 9276874 Ref: Immunohistochemical studies on Waf1p21, p16, pRb and p53 in human esophageal carcinomas and neighboring epithelia from a high-risk area in northern China. PMID: 9311588 Ref: GML sensitizes cancer cells to Taxol by induction of apoptosis. PMID: 9315106 Ref: Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications. PMID: 9321930 Ref: Clinicopathologic significance of the expression of mutated p53 protein and the proliferative activity of cancer cells in patients with esophageal squamous cell carcinoma. PMID: 9328389 Ref: p53 mutations in esophageal tumors from a high incidence area of China in relation to patient diet and smoking history. PMID: 9367071 Ref: Overexpression of GML promotes radiation-induced cell cycle arrest and apoptosis. PMID: 9425296 Ref: Pathology of esophageal cancers: local experience and current insights. PMID: 9594248 Ref: TP53 and oesophageal cancer. PMID: 9769951 Ref: High prevalence of p53 gene alterations and protein overexpression in human esophageal cancer: correlation with dietary risk factors in India. PMID: 9815606 Ref: Correlation between reduced p21(WAF1/CIP1) expression and abnormal p53 expression in esophageal carcinomas. PMID: 21528264 Ref: Alterations in p53 expression and cell proliferation in esophageal epithelia among patients from geographical areas with high or low incidence of esophageal cancer. PMID: 27041947 Ref: Changes in p53 and Waf1p21 expression and cell proliferation in esophageal carcinogenesis. PMID: 27041952 |
Ref: [The relationship between p53 mutation and esophageal cancer biological behavior]. PMID: 9456364 Ref: Clinicopathologic study of multiple primary superficial carcinoma of the esophagus. PMID: 9458370 Ref: [Molecular diagnosis of gastrointestinal cancers]. PMID: 9474927 Ref: Expression of p53 and p21WAF1/CIP1 proteins in gastric and esophageal cancers: comparison with mutations of the p53 gene. PMID: 9512119 Ref: Radiochemosensitivity and expression of p53 in patients with esophageal cancer treated by absolute noncurative resection. PMID: 9568168 Ref: [A case report of esophageal carcinoma with grade 3 response by preoperative chemotherapy using CDDP/5-FU/LV]. PMID: 9617331 Ref: Heterogeneity of p53 mutational status in esophageal squamous cell carcinoma. PMID: 9617346 Ref: Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis. PMID: 9649454 Ref: p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma. PMID: 9655287 Ref: The MDM2 gene amplification database. PMID: 9671804 Ref: Clinical significance of dendritic cell infiltration in esophageal squamous cell carcinoma. PMID: 9683832 Ref: [Immunohistochemical study of p53, p27 and PCNA expression in esophageal cancer]. PMID: 9703805 Ref: Detection of serum p53 antibodies in mucosal esophageal cancer and negative conversion after treatment. PMID: 9707082 Ref: Apoptosis in esophageal cancer following induction chemoradiotherapy. PMID: 9735235 Ref: Mitoguazone induces apoptosis via a p53-independent mechanism. PMID: 9773808 Ref: p53 gene alternation in squamous cell carcinoma of the esophagus detected by PCR-cold SSCP analysis. PMID: 9779600 Ref: p73, a gene related to p53, is not mutated in esophageal carcinomas. PMID: 9797131 Ref: p53 and p16/CDKN2 gene mutations in esophageal tumors from a high-incidence area in South Africa. PMID: 9808520 Ref: Multifocal accumulation of p53 protein in esophageal carcinoma: evidence for field cancerization. PMID: 9808524 Ref: Infection of human papillomavirus (HPV) and Epstein-Barr virus (EBV) and p53 expression in human esophageal carcinoma. PMID: 9813975 Ref: Flavopiridol mediates cell cycle arrest and apoptosis in esophageal cancer cells. PMID: 9829756 Ref: [Prognostic factors of esophageal cancer]. PMID: 9838901 Ref: The role of the human papilloma virus in esophageal cancer. PMID: 9839308 Ref: Expression and alteration of p53 and p21(waf1/cip1) influence the sensitivity of chemoradiation therapy for esophageal cancer. PMID: 9840093 Ref: Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities. PMID: 9865911 Ref: Clinical results of transhiatal esophagectomy for carcinoma of the lower thoracic esophagus according to biological markers. PMID: 10071802 Ref: p53 gene mutation in 150 dissected lymph nodes in a patient with esophageal cancer. PMID: 10071815 Ref: Overexpression of P53 and its risk factors in esophageal cancer in urban areas of Xi'an. PMID: 11819233 Ref: Molecular biology of Barrett's esophagus and esophageal cancer:role of p53. PMID: 11819298 Ref: Apoptosis and its relationship with cell proliferation, p53, Waf1p21, bcl-2 and c-myc in esophageal carcinogenesis studied with a high-risk population in northern China. PMID: 11819301 Ref: Changes of p53 protein blood level in esophageal cancer patients and normal subjects from a high incidence area in Henan, China. PMID: 11819322 |
Ref: Detection of loss of heterozygosityat microsatellite loci in esophageal squamous-cell carcinoma. PMID: 9949304 Ref: Overexpression of p53 protein associates decreased response to chemoradiotherapy in patients with esophageal carcinoma. PMID: 10102609 Ref: Usefulness of p53 protein, Bcl-2 protein and Ki-67 as predictors of chemosensitivity of malignant tumors. PMID: 10203614 Ref: Immunohistochemical analysis for cell proliferation-related protein expression in small cell carcinoma of the esophagus; a comparative study with small cell carcinoma of the lung and squamous cell carcinoma of the esophagus. PMID: 10212809 Ref: Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions. PMID: 10223186 Ref: Flow cytometric analysis and immunohistochemical staining for the p53 protein and proliferating cell nuclear antigen in submucosal carcinoma of the esophagus. PMID: 10228808 Ref: Expression of wild-type p53 gene confers increased sensitivity to radiation and chemotherapeutic agents in human esophageal carcinoma cells. PMID: 10339661 Ref: Metallothionein expression correlates with the pathological response of patients with esophageal cancer undergoing preoperative chemoradiation therapy. PMID: 10343199 Ref: Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer. PMID: 10353761 Ref: Analysis of Ki-67, p53 and Bcl-2 expression in the dysplasia-carcinoma sequence of Barrett's esophagus. PMID: 10373674 Ref: Irradiation-induced up-regulation of Fas in esophageal squamous cell carcinoma is not accompanied by Fas ligand-mediated apoptosis. PMID: 10389864 Ref: p53 in epidermoid cancer of the esophagus. PMID: 10430340 Ref: Implication of vascular endothelial growth factor in the development and metastasis of human cancers. PMID: 10457902 Ref: Expression of p53 and RB proteins in squamous cell carcinoma of the esophagus: their relationship with clinicopathologic characteristics. PMID: 10458688 Ref: Expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and p53 tumor suppressor in dysplastic progression and adenocarcinoma in Barrett esophagus. PMID: 10463972 Ref: p53, p21(Waf1/Cip1) and cyclin D1 protein expression and prognosis in esophageal cancer. PMID: 10466043 Ref: Expression of p21WAF1/Cip1 in the p53-dependent pathway is related to prognosis in patients with advanced esophageal carcinoma. PMID: 10499617 Ref: No prognostic significance of p53 expression in esophageal squamous cell carcinoma. PMID: 10518106 Ref: Detection of Epstein-Barr virus in esophageal squamous cell carcinoma in Taiwan. PMID: 10520830 Ref: Analysis of macroscopic appearance and p53 expression in superficial esophageal carcinoma. PMID: 10522005 Ref: Clinicopathological and immunohistochemical study of cancer arising from Barrett's esophagus. PMID: 10523700 Ref: Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus. PMID: 10526265 Ref: High incidence of synchronous cancer of the oral cavity and the upper gastrointestinal tract. PMID: 10529014 Ref: Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. PMID: 10601379 Ref: p53 protein expression in resected invasive esophageal cancer. PMID: 10613589 Ref: P53 gene protein overexpression predicts results of trimodality therapy in esophageal cancer patients. PMID: 10616970 Ref: Differential efficacy of suicide gene therapy by herpes simplex virus-thymidine kinase gene reflects the status of p53 gene in human esophageal cancer cells. PMID: 10628368 Ref: GPI-anchored molecule-like protein (GML) expression in non-small cell lung cancer (NSCLC). PMID: 10628393 Ref: Strategies for molecular intervention in esophageal cancers and their precursor lesions. PMID: 10631909 Ref: The prognostic significance of p53, p21 (Waf1/Cip1), and cyclin D1 protein expression in esophageal cancer patients. PMID: 10650815 Ref: [Histological and molecular prognostic factors in esophageal cancer]. PMID: 10714193 Ref: Esophageal cancer. PMID: 17023973 |
Ref: Novel polymorphism in p21(waf1/cip1) cyclin dependent kinase inhibitor gene: association with human esophageal cancer. PMID: 10656678 Ref: Esophageal small cell carcinomas: clinicopathologic parameters, p53 overexpression, proliferation marker, and their impact on pathogenesis. PMID: 10656731 Ref: Modern pathology: prognostic parameters in squamous cell carcinoma of the esophagus. PMID: 10693235 Ref: Circulating p53 antibodies, p53 gene mutational profile and product accumulation in esophageal squamous-cell carcinoma in India. PMID: 10709097 Ref: High frequency in esophageal cancers of p53 alterations inactivating the regulation of genes involved in cell cycle and apoptosis. PMID: 10753186 Ref: Detection of circulating anti-p53 antibodies in esophageal cancer patients. PMID: 10754600 Ref: Integrated p53 histopathologic/genetic analysis of premalignant lesions of the esophagus. PMID: 10757119 Ref: Mutations in zinc-binding domains of p53 as a prognostic marker of esophageal-cancer patients. PMID: 10761706 Ref: Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells. PMID: 10778992 Ref: Nitrotyrosine in esophageal squamous cell carcinoma and relevance to p53 expression. PMID: 10779640 Ref: Immunohistochemical status of the p53 protein and Ki-67 antigen using biopsied specimens can predict a sensitivity to neoadjuvant therapy in patients with esophageal cancer. PMID: 10791203 Ref: Biological evaluation of undifferentiated carcinoma of the esophagus. PMID: 10791851 Ref: p53 polymorphism in human papillomavirus-associated esophageal cancer. PMID: 10850407 Ref: Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer. PMID: 10873097 Ref: Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict. PMID: 10911913 Ref: Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation. PMID: 10914734 Ref: Expression of p53 and p21 is useful for the prediction of preoperative chemotherapeutic effects in esophageal carcinoma. PMID: 10928129 Ref: Apoptosis and cell proliferation in esophageal sqamous cell carcinoma treated by chemotherapy. PMID: 10960772 Ref: Molecular biology of esophageal cancer. PMID: 10967750 Ref: [The protocol of clinical trial and basic experiments for esophageal cancer using gene transduction]. PMID: 11004829 Ref: Combined analysis of p53 and retinoblastoma protein expressions in esophageal cancer. PMID: 11016333 Ref: Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus. PMID: 11020858 Ref: Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma. PMID: 11042560 Ref: [Chemoradiotherapy with low-dose cisplatin and 5-FU for advanced esophageal cancer]. PMID: 11086419 Ref: Role in tumorigenesis of silent mutations in the TP53 gene. PMID: 11106801 Ref: CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers. PMID: 11156245 Ref: Malignant potential and cytogenetic characteristics of occult disseminated tumor cells in esophageal cancer. PMID: 11156375 Ref: Expression of p53, bcl-2, and bax as predictors of response to radiotherapy in esophageal cancer. PMID: 11206630 Ref: Clinicopathological studies of esophageal carcinoma in achalasia: analyses of carcinogenesis using histological and immunohistochemical procedures. PMID: 11268444 Ref: Histopathological analysis of non-malignant and malignant epithelium in achalasia of the esophagus. PMID: 14601900 |
Ref: Expression of cyclin D1 and p53 and its correlation with proliferative activity in the spectrum of esophageal carcinomas induced after duodenal content reflux and 2,6-dimethylnitrosomorpholine administration in rats. PMID: 11181448 Ref: [Perspectives on postgenome medicine: Gene therapy for esophageal cancer]. PMID: 11197868 Ref: A case of esophageal sarcomatoid carcinoma with molecular evidence of a monoclonal origin. PMID: 11209815 Ref: Combinatory anti-tumor effects of electroporation-mediated chemotherapy and wild-type p53 gene transfer to human esophageal cancer cells. PMID: 11251180 Ref: Bax expression as a prognostic marker of postoperative chemoradiotherapy for patients with esophageal cancer. PMID: 11254884 Ref: Clinical and experimental evidence of Bcl-2 involvement in the response to photodynamic therapy. PMID: 11299823 Ref: Unusual profile and high prevalence of p53 mutations in esophageal squamous cell carcinomas from northern Iran. PMID: 11306496 Ref: Differential expression of retinoic acid receptors and p53 protein in normal, premalignant, and malignant esophageal tissues. PMID: 11315258 Ref: Genistein, a tyrosine kinase inhibitor, enhanced radiosensitivity in human esophageal cancer cell lines in vitro: possible involvement of inhibition of survival signal transduction pathways. PMID: 11316564 Ref: Expression of p53 protein related to smoking and alcoholic beverage drinking habits in patients with esophageal cancers. PMID: 11323100 Ref: Thymidine phosphorylase expression causes both the increase of intratumoral microvessels and decrease of apoptosis in human esophageal carcinomas. PMID: 11328530 Ref: Gastric dysplasia-like epithelial atypia associated with chemoradiotherapy for esophageal cancer: a clinicopathologic and immunohistochemical study of 15 cases. PMID: 11353047 Ref: Flow cytometric DNA analysis, and immunohistochemical p53, PCNA and histopathologic study in primary achalasia: preliminary results. PMID: 11379319 Ref: Prognostic value of p53 mutations in patients with locally advanced esophageal carcinoma treated with definitive chemoradiotherapy. PMID: 11388392 Ref: Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma. PMID: 11448381 Ref: Metastatic adenocarcinoma of the esophagus to the skin: new patterns of tumor recurrence and alternate treatments for palliation. PMID: 11493381 Ref: Presence of serum p53 antibodies is associated with decreased in vitro chemosensitivity in patients with esophageal cancer. PMID: 11495153 Ref: Preclinical study of adenoviral p53 gene therapy for esophageal cancer. PMID: 11495154 Ref: An immunohistochemical examination of basaloid squamous cell carcinoma of the esophagus: report of a case. PMID: 11495163 Ref: Clinical significance and prognostic value of apoptosis related proteins in superficial esophageal squamous cell carcinoma. PMID: 11508622 Ref: Detection of human papillomavirus DNA and p53 gene mutations in esophageal cancer samples and adjacent normal mucosa. PMID: 11549832 Ref: Atypical adenomatous hyperplasia of the lung in autopsy cases. PMID: 11551410 Ref: Immunohistochemical and clinicopathologic analysis of response to neoadjuvant therapy for esophageal squamous cell carcinoma. PMID: 11553227 Ref: Accumulation of p53 in esophageal squamous cell carcinoma. PMID: 11562772 Ref: Tumor marker expression is predictive of survival in patients with esophageal cancer. PMID: 11565671 Ref: Reduced Fhit expression occurs in the early stage of esophageal tumorigenesis: no correlation with p53 expression and apoptosis. PMID: 11574776 Ref: Esophageal squamous cell carcinomas with DNA replication errors (RER+) are associated with p16/pRb loss and wild-type p53. PMID: 11599796 Ref: Alterations in MDM2 expression in esophageal squamous cell carcinoma: relationship with p53 status. PMID: 11692147 Ref: Mutational spectrum induced by acetaldehyde in the HPRT gene of human T lymphocytes resembles that in the p53 gene of esophageal cancers. PMID: 11698345 Ref: [Immunohistochemical study of dihydropyrimidine dehydrogenase (DPD) and p53 in biopsied specimens of esophageal cancer before chemoradiotherapy]. PMID: 11707971 Ref: Screening and surveillance for complications related to gastroesophageal reflux disease. PMID: 11749938 Ref: [Abnormal expression of p53, Ki67 and iNOS in human esophageal carcinoma in situ and pre-malignant lesions]. PMID: 11783017 Ref: [Detection of HPV in human esophageal cancer in high-incidence area and its correlation with p53 expression]. PMID: 11783091 Ref: p53 immunoreactivity in Barrett's metaplasia, dysplasia, and adenocarcinoma--a case report. PMID: 11813596 Ref: Circulating anti-p53 antibodies in esophageal cancer patients. PMID: 11820593 |
Ref: Biopsy specimen microvessel density is a useful prognostic marker in patients with T(2-4)M(0) esophageal cancer treated with chemoradiotherapy. PMID: 11801548 Ref: Risk factors for esophageal cancer and the multiple occurrence of carcinoma in the upper aerodigestive tract. PMID: 11821780 Ref: The relation of alcohol consumption and cigarette smoking to the multiple occurrence of esophageal dysplasia and squamous cell carcinoma. PMID: 11821781 Ref: Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33(ING1) in T.Tn human esophageal carcinoma cells. PMID: 11850840 Ref: Restoration of wild-type conformation and activity of a temperature-sensitive mutant of p53 (p53(V272M)) by the cytoprotective aminothiol WR1065 in the esophageal cancer cell line TE-1. PMID: 11870884 Ref: p53 Gene mutation and genetic instability in superficial multifocal esophageal squamous cell carcinoma. PMID: 11894109 Ref: The abnormal expression of retinoic acid receptor-beta, p 53 and Ki67 protein in normal, premalignant and malignant esophageal tissues. PMID: 11925591 Ref: Clinical prognostic values of vascular endothelial growth factor, microvessel density,and p53 expression in esophageal carcinomas. PMID: 11961303 Ref: [Quantitive detection of multi-gene expressions and DNA content in the precancerous cells of esophageal carcinoma]. PMID: 11977632 Ref: [Gene therapy for esophageal cancer]. PMID: 11993227 Ref: Predictive factors for success of neo-adjuvant therapy in upper gastrointestinal cancer. PMID: 12000603 Ref: Endoscopic screening and determination of p53 and proliferating cell nuclear antigen in esophageal multistage carcinogenesis: a comparative study between high- and low-risk populations in Henan, northern China. PMID: 12060048 Ref: [Molecular alterations in esophageal cancer]. PMID: 12094695 Ref: Prognostic significance of serum p53 antibody in patients with esophageal squamous cell carcinoma. PMID: 12110794 Ref: Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. PMID: 12115375 Ref: Adenovirus-mediated p14ARF gene transfer cooperates with Ad5CMV-p53 to induce apoptosis in human cancer cells. PMID: 12162819 Ref: Molecular and genetic characterization of a non-metastatic human esophageal cancer cell line, T.Tn expressing non-functional mutated p53. PMID: 12168098 Ref: p53 null mutations detected by a p53 yeast functional assay predict a poor outcome in young esophageal carcinoma patients. PMID: 12168111 Ref: Elevated susceptibility of the p53 knockout mouse esophagus to methyl-N-amylnitrosamine carcinogenesis. PMID: 12189199 Ref: Cell cycle-regulated factors in esophageal cancer. PMID: 12220423 Ref: No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. PMID: 12430182 Ref: Elevated expression of p63 protein in human esophageal squamous cell carcinomas. PMID: 12447998 Ref: p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. PMID: 12467072 Ref: [Association of p53, PCNA expression and trace element content in esophageal mucosa]. PMID: 12479101 Ref: Biological properties of biopsy specimens are useful for predicting lymph node micrometastasis in esophageal carcinoma. PMID: 12530024 Ref: p53 gene therapy for esophageal cancer. PMID: 12572873 Ref: [New strategies in the treatment of esophageal cancer]. PMID: 12592216 Ref: The role of tumor suppressor genes in esophageal cancer. PMID: 12592219 Ref: Histopathological diagnosis of biopsy samples from early esophageal carcinoma. PMID: 12636112 |
Ref: Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China. PMID: 12508343 Ref: Diagnosis of esophagogastric tumors. PMID: 12510224 Ref: Cell culture in esophageal squamous cell carcinoma and the association with molecular markers. PMID: 12538476 Ref: Titration of serum p53 antibodies in 1,085 patients with various types of malignant tumors: a multiinstitutional analysis by the Japan p53 Antibody Research Group. PMID: 12548611 Ref: Polymorphisms and mutations found in the regions flanking exons 5 to 8 of the TP53 gene in a population at high risk for esophageal cancer in South Africa. PMID: 12550754 Ref: On the nature of genetic changes required for the development of esophageal cancer. PMID: 12557264 Ref: Apoptotic and proliferative indexes in esophageal cancer: predictors of response to neoadjuvant therapy [corrected]. PMID: 12559188 Ref: Treatment response and prognosis of patients after recurrence of esophageal cancer. PMID: 12563234 Ref: Detection of serum p53 protein in patients with different gastrointestinal cancers. PMID: 12670524 Ref: Common genetic variants of TP53 and BRCA2 in esophageal cancer patients and healthy individuals from low and high risk areas of northern China. PMID: 12670525 Ref: [Relation between helicobacter pylori L-form infection and tumor angiogenesis in human esophageal carcinoma]. PMID: 12678988 Ref: Simultaneous use of DGGE and DHPLC to screen TP53 mutations in cancers of the esophagus and cardia from a European high incidence area (Lower Normandy, France). PMID: 12714698 Ref: Survivin gene expression positively correlates with proliferative activity of cancer cells in esophageal cancer. PMID: 12743425 Ref: Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study. PMID: 12771886 Ref: Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. PMID: 12800215 Ref: [Analysis of p53 mutational spectra of esophageal squamous cell carcinomas from Linzhou, comparison with esophageal and other cancers from other areas]. PMID: 12816712 Ref: Prognostic value of p53 protein expression and vascular endothelial growth factor expression in resected squamous cell carcinoma of the esophagus. PMID: 12823209 Ref: Synergistic decline in expressions of p73 and p21 with invasion in esophageal cancers. PMID: 12841870 Ref: Prediction of lymph node metastasis by p53, p21(Waf1), and PCNA expression in esophageal cancer patients. PMID: 12866574 Ref: Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (review). PMID: 12883749 Ref: [Progress of gene therapy for esophageal cancer in Japan]. PMID: 12894708 Ref: [p53 gene polymorphism with susceptibility to esophageal cancer and lung cancer in Chinese population]. PMID: 12921568 Ref: [A case report of an advanced esophageal carcinoma (stage II) without signs of recurrence in 5 years after chemoradiotherapy. With reference to p53 immunohistochemistry as an indicator for prognostic evaluation of chemoradiotherapy]. PMID: 14524242 Ref: Immunohistochemistry analysis of micrometastasis in pretreatment lymph nodes from patients with esophageal cancer. PMID: 14529974 Ref: Reduced MLH1 expression after chemotherapy is an indicator for poor prognosis in esophageal cancers. PMID: 14555508 Ref: Flow cytometric analysis of DNA, telomerase content and multi-gene expression in esophageal epithelial dysplasia. PMID: 14606066 Ref: c-erbB-2 oncoprotein expression related to chemoradioresistance in esophageal squamous cell carcinoma. PMID: 14630269 Ref: [Cyclooxygenase-2 expression in esophageal cancer cells and induction by mitomycin C]. PMID: 14633464 Ref: Mutation of the p53 gene predicts lymph node metastases in Japanese patients with esophageal carcinoma: DNA and immunohistochemical analyses. PMID: 14641293 Ref: Mechanisms of esophageal cancer development in Brazilians. PMID: 14644339 Ref: Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapy. PMID: 14695149 Ref: Apoptotic and proliferative indexes in esophageal cancer: Predictors of response to neoadjuvant therapy apoptosis and proliferation in esophageal cancer. PMID: 29340962 |
Ref: The multistage process of carcinogenesis in human esophageal epithelial cells induced by human papillomavirus. PMID: 14767516 Ref: [Correlation between serum p53 antibody and chemosensitivity in patient with esophageal cancer]. PMID: 15087041 Ref: Cytogenetic alterations in chagasic achalasia compared to esophageal carcinoma. PMID: 15104278 Ref: Molecular biology of esophageal cancer. PMID: 15138356 Ref: Selective inhibition of survival signal transduction pathways enhanced radiosensitivity in human esophageal cancer cell lines in vitro. PMID: 15161032 Ref: Pretreatment evaluation of combined HIF-1alpha, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer. PMID: 15170665 Ref: Growth suppression of esophageal squamous cell carcinoma induced by heavy carbon-ion beams combined with p53 gene transfer. PMID: 15289857 Ref: Mutational spectra of p53 in geographically localized esophageal squamous cell carcinoma groups in China. PMID: 15305417 Ref: [Analysis of p53 gene mutation in esophageal exfoliative cells]. PMID: 15312345 Ref: Predictive effect of p53 and p21 alteration on chemotherapy response and survival in locally advanced adenocarcinoma of the esophagus. PMID: 15330218 Ref: p53 polymorphism in human papillomavirus-associated Kazakh's esophageal cancer in Xinjiang, China. PMID: 15334668 Ref: Bax is an important determinant for radiation sensitivity in esophageal carcinoma cells. PMID: 15375604 Ref: p150 overexpression in gastric carcinoma: the association with p53, apoptosis and cell proliferation. PMID: 15382063 Ref: Basaloid squamous cell carcinoma of the esophagus with or without adenoid cystic features. PMID: 15387711 Ref: Clinicopathological and biological characteristics of esophageal squamous cell carcinoma associated with head and neck cancer. PMID: 15539912 Ref: [Significance of p53 gene mutation and P53 protein expression abnormality on the prognosis of esophageal cancer: a meta-analysis study]. PMID: 15555357 Ref: Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer. PMID: 15557792 Ref: Expression of p21(Waf1/Cip1) predicts response and survival of esophageal cancer patients treated by chemoradiotherapy. PMID: 15569370 Ref: Prognostic value of microvessel density, matrix metalloproteinase-9 and p53 protein expression in esophageal cancer. PMID: 16116499 |
Ref: p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis. PMID: 15386362 Ref: DHPLC is superior to SSCP in screening p53 mutations in esophageal cancer tissues. PMID: 15523690 Ref: The mutagenic potential of duodenoesophageal reflux. PMID: 15621992 Ref: Detection of JC virus DNA sequences and expression of viral T antigen and agnoprotein in esophageal carcinoma. PMID: 15630684 Ref: p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. PMID: 15639342 Ref: [Aurora kinases and cancer]. PMID: 15675572 Ref: Is there a set of histologic changes that are invariably reflux associated? PMID: 15679411 Ref: Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival. PMID: 15693850 Ref: The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage. PMID: 15703811 Ref: Expression of hypoxia-inducible factor-1alpha in esophageal squamous cell carcinoma. PMID: 15771621 Ref: [Gene therapy for esophageal cancer]. PMID: 15773346 Ref: Loss of heterozygosity in multistage carcinogenesis of esophageal carcinoma at high-incidence area in Henan Province, China. PMID: 15810068 Ref: Immunohistochemistry of p53, Bcl-2, and Ki-67 as predictors of chemosensitivity. PMID: 15901938 Ref: Mutations of p53 gene exons 4-8 in human esophageal cancer. PMID: 15902745 Ref: p53 immunoexpression: an aid to conventional methods in the screening of precursor lesions of squamous esophageal cancer in patients at high-risk? PMID: 15936591 Ref: [Expression of retinoic acid receptor-beta mRNA and p16, p53, Ki67 proteins in esophageal carcinoma and its precursor lesions]. PMID: 15946564 Ref: Serum p53 antibodies in drainage blood from the azygos vein in patients with esophageal carcinoma. PMID: 16101132 Ref: Expression of p53 protein in esophageal squamous cell carcinoma: relation to hypoxia-inducible factor-1alpha, angiogenesis and apoptosis. PMID: 16127293 Ref: p53--prognostic factor of malignant transformation of Barrett's esophagus. PMID: 16170400 Ref: Creating oral squamous cancer cells: a cellular model of oral-esophageal carcinogenesis. PMID: 16239349 Ref: Environmental exposure and p53 mutations in esophageal cancer patients in areas of low and high incidence of esophageal cancer in China. PMID: 16272802 Ref: Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma. PMID: 16273238 Ref: The molecular biology of esophageal adenocarcinoma. PMID: 16299787 Ref: [Inhibitory effects of esophageal cancer related gene 2 on proliferation of human esophageal cancer cell EC9706]. PMID: 16324322 Ref: Dual effects of 8-Br-cAMP on differentiation and apoptosis of human esophageal cancer cell line Eca-109. PMID: 16425431 Ref: Epidemiology and molecular biology of Barrett esophagus. PMID: 16428034 |
Ref: The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer. PMID: 16318864 Ref: True carcinosarcoma of the esophagus. PMID: 16364045 Ref: Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells. PMID: 16434257 Ref: Id-1 promotes proliferation of p53-deficient esophageal cancer cells. PMID: 16506209 Ref: Distribution of p53 mutations in esophageal and gastric carcinomas and the relationship with p53 expression. PMID: 16525665 Ref: Zinc deficiency potentiates induction and progression of lingual and esophageal tumors in p53-deficient mice. PMID: 16543248 Ref: P53, COX-2, iNOS protein expression changes and their relationship with anti-oxidant enzymes in surgically and multi-modality treated esophageal carcinoma patients. PMID: 16572897 Ref: Comparative integromics on Ephrin family. PMID: 16596216 Ref: Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB. PMID: 16682957 Ref: Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma. PMID: 16734736 Ref: Prognostic factors after chemoradiotherapy for patients with inoperable esophageal squamous cell carcinoma. PMID: 16795974 Ref: A study on p53 gene alterations in esophageal squamous cell carcinoma and their correlation to common dietary risk factors among population of the Kashmir valley. PMID: 16810754 Ref: A multiplex tissue immunoblotting assay for proteomic profiling: a pilot study of the normal to tumor transition of esophageal squamous cell carcinoma. PMID: 16835344 Ref: Genomic instability in precancerous lesions before inactivation of tumor suppressors p53 and APC in patients. PMID: 16855398 Ref: Expression of Egr-1 gene and its correlation with the oncogene proteins in non-irradiated and irradiated esophageal squamous cell carcinoma. PMID: 16866858 Ref: Capsaicin induced cell cycle arrest and apoptosis in human esophagus epidermoid carcinoma CE 81T/VGH cells through the elevation of intracellular reactive oxygen species and Ca2+ productions and caspase-3 activation. PMID: 16942782 Ref: Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma. PMID: 17069588 Ref: Relationship between HPV16/18 E6 and 53, 21WAF1, MDM2, Ki67 and cyclin D1 expression in esophageal squamous cell carcinoma: comparative study by using tissue microarray technology. PMID: 17080019 Ref: Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression. PMID: 17121882 Ref: Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tract. PMID: 17163161 Ref: Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma. PMID: 17576439 Ref: p53 Mutation analysis of low-grade dysplasia and high-grade dysplasia/carcinoma in situ of the esophagus using laser capture microdissection. PMID: 17652955 |
Ref: Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation. PMID: 16488074 Ref: Multistage carcinogenesis in Barrett's esophagus. PMID: 16713672 Ref: Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. PMID: 17081685 Ref: The evidence base of proton pump inhibitor chemopreventative agents in Barrett's esophagus--the good, the bad, and the flawed! PMID: 17266685 Ref: Collision carcinoma of the residual cervical esophagus 27 years after esophageal cancer surgery. PMID: 17348434 Ref: The flavonoid component isorhamnetin in vitro inhibits proliferation and induces apoptosis in Eca-109 cells. PMID: 17368593 Ref: The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas. PMID: 17384664 Ref: p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort. PMID: 17390072 Ref: Modification of the Rb-binding domain of replication-competent adenoviral vector enhances cytotoxicity against human esophageal cancers via NF-kappaB activity. PMID: 17518613 Ref: p53 gene mutations in esophageal squamous cell carcinoma and their relevance to etiology and pathogenesis: results in Japan and comparisons with other countries. PMID: 17573896 Ref: Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tract. PMID: 17607914 Ref: Downregulation of p63 upon exposure to bile salts and acid in normal and cancer esophageal cells in culture. PMID: 17615180 Ref: Expression of p53, p16 and cyclooxygenase-2 in esophageal cancer with tissue microarray. PMID: 17650224 Ref: Genetic polymorphisms and esophageal cancer risk. PMID: 17674367 Ref: p53 and MIB-1 expression of esophageal carcinoma concominant with achalasia. PMID: 17708270 Ref: Expressions of p53, VEGF C, p21: could they be used in preoperative evaluation of lymph node metastasis of esophageal squamous cell carcinoma? PMID: 17760650 Ref: Expression of p53 and p21 and the clinical response for hyperthermochemoradiotherapy in patients with squamous cell carcinoma of the esophagus. PMID: 17972508 Ref: The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation. PMID: 17974918 Ref: Analysis of R213R and 13494 g-->a polymorphisms of the p53 gene in individuals with esophagitis, intestinal metaplasia of the cardia and Barrett's Esophagus compared with a control group. PMID: 18923929 Ref: Studies on Association Between Copper Excess, Zinc Deficiency and TP53 Mutations in Esophageal Squamous Cell Carcinoma From Kashmir Valley, India-A High Risk Area. PMID: 21475450 |
Ref: T-type Ca2+ channel expression in human esophageal carcinomas: a functional role in proliferation. PMID: 17532042 Ref: Interplay between oncoproteins and antioxidant enzymes in esophageal carcinoma treated without and with chemoradiotherapy: a prospective study. PMID: 18207033 Ref: Acetaldehyde-induced mutational pattern in the tumour suppressor gene TP53 analysed by use of a functional assay, the FASAY (functional analysis of separated alleles in yeast). PMID: 18242117 Ref: Recent advances in esophageal cancer gene therapy. PMID: 18292732 Ref: P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations. PMID: 18330889 Ref: Characterization of one newly established esophageal cancer cell line CSEC from a high-incidence area in China. PMID: 18477252 Ref: Gene therapy for esophageal squamous cell carcinoma. PMID: 18508438 Ref: Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays. PMID: 18519675 Ref: Predictive factors of the response to chemoradiotherapy in esophageal cancer. PMID: 18555630 Ref: Changes of serum p53 antibodies and clinical significance of radiotherapy for esophageal squamous cell carcinoma. PMID: 18609695 Ref: Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. PMID: 18666234 Ref: Comparative proteomic analysis reveals differentially expressed proteins regulated by a potential tumor promoter, BRE, in human esophageal carcinoma cells. PMID: 18756325 Ref: Relationship between p53 expression and gastric cancers in cardia and antrum. PMID: 18759514 Ref: Association between copper excess, zinc deficiency, and TP53 mutations in esophageal squamous cell carcinoma from Kashmir Valley, India--a high risk area. PMID: 18791921 Ref: Concomitant presence of mutations in mitochondrial genome and p53 in cancer development - a study in north Indian sporadic breast and esophageal cancer patients. PMID: 18792899 Ref: Total number of genome alterations in sporadic gastrointestinal cancer inferred from pooled analyses in the literature. PMID: 19023234 Ref: [Do locally advanced esophageal cancer still need surgery?]. PMID: 19046920 Ref: [p53, p16 E COX-2 expression in esophageal squamous cell carcinoma and histopathological association]. PMID: 19148359 |
Ref: Protein alterations in ESCC and clinical implications: a review. PMID: 18564170 Ref: Increased p53 expression in the malignant transformation of Barrett's esophagus is accompanied by an upward shift of the proliferative compartment. PMID: 18752044 Ref: Survivin expression in esophageal cancer: correlation with p53 mutations and promoter polymorphism. PMID: 19018856 Ref: Perioperative changes of serum p53 antibody titer is a predictor for survival in patients with esophageal squamous cell carcinoma. PMID: 19052812 Ref: Notch1 signaling inhibits growth of EC109 esophageal carcinoma cells through downmodulation of HPV18 E6/E7 gene expression. PMID: 19122673 Ref: Expression of Akt and Mdm2 in human esophageal squamous cell carcinoma. PMID: 19124015 Ref: Correlations between selected tumor markers and fluorodeoxyglucose maximal standardized uptake values in esophageal cancer. PMID: 19136271 Ref: p53 Mutations in carcinoma of the esophagus and gastroesophageal junction. PMID: 19160092 Ref: Decrease in chemosensitivity against anticancer drugs by an esophageal squamous cell carcinoma SEREX antigen, AISEC. PMID: 19212668 Ref: Cytotoxicity of adenoviruses expressing the wild-type p53 gene to esophageal carcinoma cells is linked with the CAR expression level and indirectly with the endogenous p53 status. PMID: 19363469 Ref: p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis. PMID: 19383811 Ref: RNA interference-mediated knockdown of p21(WAF1) enhances anti-tumor cell activity of oncolytic adenoviruses. PMID: 19407849 Ref: Gene mutations in esophageal mucosa of chagas disease patients. PMID: 19414370 Ref: Activation of NFAT signal by p53-K120R mutant. PMID: 19416725 Ref: Immunohistochemical analysis of selected molecular markers in esophagus precancerous, adenocarcinoma and squamous cell carcinoma in Iranian subjects. PMID: 19679052 Ref: A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation. PMID: 19735873 Ref: Esophageal Carcinoma with Triplicate Differentiation into Squamous Cell Carcinoma, Small Cell Carcinoma and Adenocarcinoma: a Case Report. PMID: 27956965 |
Ref: Ewing sarcoma and primitive neuroectodermal tumor of the esophagus: report of a case and review of literature. PMID: 18499684 Ref: TP53 mutation profile of esophageal squamous cell carcinomas of patients from Southeastern Brazil. PMID: 19944185 Ref: p21 Waf1/Cip1 polymorphisms and risk of esophageal cancer. PMID: 20112071 Ref: Expression of p53 as predictor for the development of esophageal cancer in achalasia patients. PMID: 20113324 Ref: Viral shedding after p53 adenoviral gene therapy in 10 cases of esophageal cancer. PMID: 20175784 Ref: Interactions of the p53 protein family in cellular stress response in gastrointestinal tumors. PMID: 20197393 Ref: Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line. PMID: 20236666 Ref: Upregulation of SPRR3 promotes colorectal tumorigenesis. PMID: 20379613 Ref: p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma. PMID: 20388212 Ref: Pro variant of TP53 Arg72Pro contributes to esophageal squamous cell carcinoma risk: evidence from a meta-analysis. PMID: 20389250 Ref: Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor-invasive signature in esophageal cancer. PMID: 20516120 Ref: Characterization of DeltaNp73 expression and regulation in gastric and esophageal tumors. PMID: 20676143 Ref: Combinatory cytotoxic effects produced by E1B-55kDa-deleted adenoviruses and chemotherapeutic agents are dependent on the agents in esophageal carcinoma. PMID: 20689571 Ref: [Microarray analysis of tumor xenograft model]. PMID: 20716879 Ref: Genetic polymorphism of p53, but not GSTP1, is association with susceptibility to esophageal cancer risk - a meta-analysis. PMID: 20827430 Ref: LATS tumor suppressor: a new governor of cellular homeostasis. PMID: 20935475 Ref: The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma. PMID: 20937111 Ref: [Pathology and pathobiology of the oesophageal carcinoma]. PMID: 20954310 Ref: Detection of the risk of adenocarcinoma in Barrett's esophagus by means of tumor markers (p53 and Ki67). PMID: 21049770 Ref: Specific intronic p53 mutation in esophageal squamous cell carcinoma in Southern Thailand. PMID: 21072901 Ref: [Tumor-suppressing function of human esophageal cancer related gene 4 in esophageal squamous cell carcinoma]. PMID: 21162904 |
Ref: Neuroendocrine carcinoma of the esophagus: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA. PMID: 20354820 Ref: Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma. PMID: 21084391 Ref: c-Myc inhibits TP53INP1 expression via promoter methylation in esophageal carcinoma. PMID: 21219856 Ref: Copy-neutral loss of heterozygosity at the p53 locus in carcinogenesis of esophageal squamous cell carcinomas associated with p53 mutations. PMID: 21325068 Ref: TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis. PMID: 21448430 Ref: Transcriptional factor Prox1 plays an essential role in the antiproliferative action of interferon-gamma in esophageal cancer cells. PMID: 21452064 Ref: Occurrence of multipolar mitoses and association with Aurora-A/-B kinases and p53 mutations in aneuploid esophageal carcinoma cells. PMID: 21470402 Ref: Association of TP53 intron 3, 16 bp duplication polymorphism with esophageal and gastric cancer susceptibility in Kashmir Valley. PMID: 21473292 Ref: p53 codon 72 polymorphism and the risk of esophageal cancer: a Korean case-control study. PMID: 21595775 Ref: p53 protein accumulation, iodine-unstained lesions, and alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 genotypes in Japanese alcoholic men with esophageal dysplasia. PMID: 21601984 Ref: Gene mutations and polymorphisms of TP53 and FHIT in chronic esophagitis and esophageal carcinoma. PMID: 21617227 Ref: Loss of transcription factor KLF5 in the context of p53 ablation drives invasive progression of human squamous cell cancer. PMID: 21868761 Ref: Efficacy and drawbacks of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the thoracic esophagus. PMID: 21937381 Ref: Barrett's esophagus: treatments of adenocarcinomas II. PMID: 21950818 Ref: KIT and PDGFRA in esophageal pure small cell carcinoma. PMID: 22076173 Ref: The prolyl isomerase Pin1 is overexpressed in human esophageal cancer. PMID: 22848287 |
Ref: Role of p53 and p73 genes polymorphisms in susceptibility to esophageal cancer: a case control study in a northern Indian population. PMID: 21573788 Ref: Immunohistochemical evaluation of p53, FHIT, and IGF2 gene expression in esophageal cancer. PMID: 21668571 Ref: Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma. PMID: 22200953 Ref: Radiation sensitivity of esophageal adenocarcinoma: the contribution of the RNA-binding protein RNPC1 and p21-mediated cell cycle arrest to radioresistance. PMID: 22214381 Ref: Clear cell variant of squamous cell carcinoma originating in the esophagus: report of a case with immunohistochemical and oncogenetic analyses. PMID: 22243784 Ref: Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells. PMID: 22292433 Ref: Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy. PMID: 22448886 Ref: Esophageal combined carcinomas: Immunohoistochemical and molecular genetic studies. PMID: 22509088 Ref: p53 and p73 expression in esophageal carcinoma correlate with clinicopathology of tumors. PMID: 22534503 Ref: Early evaluation of the apoptotic index ratio is useful in predicting the efficacy of chemoradiotherapy in esophageal squamous cell carcinoma. PMID: 22740896 Ref: Fhit, E-cadherin, p53, and activation-induced cytidine deaminase expression in endoscopically resected early stage esophageal squamous neoplasia. PMID: 22742976 Ref: Effect of altered WIG-1 expression on DDP sensitivity in a DDP-resistant esophageal squamous cancer cell line. PMID: 22794122 Ref: High-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations. PMID: 22870241 Ref: p53 mutation alters the effect of the esophageal tumor suppressor KLF5 on keratinocyte proliferation. PMID: 22990386 Ref: Identification, characterization and application of a G-quadruplex structured DNA aptamer against cancer biomarker protein anterior gradient homolog 2. PMID: 23029506 Ref: Metallothioneins and zinc in cancer diagnosis and therapy. PMID: 23050852 Ref: p53 Codon 72 arginine/proline polymorphism and cancer in Sudan. PMID: 23053979 Ref: Suppression of hepatocarcinoma model in vitro and in vivo by ECRG2 delivery using adenoviral vector. PMID: 23079671 Ref: Potential diagnostic value of serum p53 antibody for detecting esophageal cancer: a meta-analysis. PMID: 23285221 |
Ref: Correlation of telomere length shortening with TP53 somatic mutations, polymorphisms and allelic loss in breast tumors and esophageal cancer. PMID: 23124483 Ref: TP53 gene deletion in esophageal cancer tissues of patients and its clinical significance. PMID: 23128792 Ref: SnoN/SKIL modulates proliferation through control of hsa-miR-720 transcription in esophageal cancer cells. PMID: 23154181 Ref: Correlation analysis of c-myc, p21(WAF/CIP1), p53, C-erbB-2 and COX-2 proteins in esophageal squamous cell carcinoma. PMID: 23177619 Ref: Improvement of endocytoscopic findings after per oral endoscopic myotomy (POEM) in esophageal achalasia; does POEM reduce the risk of developing esophageal carcinoma? Per oral endoscopic myotomy, endocytoscopy and carcinogenesis. PMID: 23363448 Ref: Genetic variants in DNA repair pathway genes and risk of esophageal squamous cell carcinoma and gastric adenocarcinoma in a Chinese population. PMID: 23504502 Ref: Correlation of p53 status with the response to chemotherapy-based treatment in esophageal cancer: a meta-analysis. PMID: 23515910 Ref: Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. PMID: 23525077 Ref: PIK3CA mutation is associated with a favorable prognosis among patients with curatively resected esophageal squamous cell carcinoma. PMID: 23532889 Ref: Epstein-Barr virus associated lymphoepithelial carcinoma of the esophagus. PMID: 23573354 Ref: Jaridonin, a novel ent-kaurene diterpenoid from Isodon rubescens, inducing apoptosis via production of reactive oxygen species in esophageal cancer cells. PMID: 23597192 Ref: OSU-03012, a non-Cox inhibiting celecoxib derivative, induces apoptosis of human esophageal carcinoma cells through a p53/Bax/cytochrome c/caspase-9-dependent pathway. PMID: 23652278 Ref: The determination of genetic markers of age-related cancer pathologies in populations from Kazakhstan. PMID: 23675381 Ref: The role of cellular senescence in the gastrointestinal mucosa. PMID: 23710306 Ref: Association of p53 Arg72Pro polymorphism with esophageal cancer: a meta-analysis based on 14 case-control studies. PMID: 23844939 Ref: Periostin cooperates with mutant p53 to mediate invasion through the induction of STAT1 signaling in the esophageal tumor microenvironment. PMID: 23917221 Ref: Role of Human papilloma virus infection and altered methylation of specific genes in esophageal cancer. PMID: 23991974 Ref: p53 immunohistochemical expression and patient prognosis in esophageal squamous cell carcinoma. PMID: 24026664 Ref: Physiological beta-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma. PMID: 24073846 Ref: Distinct genetic aberrations in oesophageal adeno and squamous carcinoma. PMID: 24102414 Ref: Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer. PMID: 24206575 Ref: SIRT1 is a useful biomarker for high-grade dysplasia and carcinoma in Barrett's esophagus. PMID: 24247792 Ref: [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma]. PMID: 24314216 Ref: Metformin inhibits esophagus cancer proliferation through upregulation of USP7. PMID: 24335168 Ref: Barrett's esophageal carcinoma consisting of undifferentiated carcinoma and differentiated adenocarcinoma: report of case. PMID: 26181597 |
Ref: Modeling gene-environment interactions in oral cavity and esophageal cancers demonstrates a role for the p53 R72P polymorphism in modulating susceptibility. PMID: 23475592 Ref: Clinicopathological features of narrow-band imaging endoscopy and immunohistochemistry in ultraminute esophageal squamous neoplasms. PMID: 23796261 Ref: Combination treatment with paclitaxel and doxorubicin inhibits growth of human esophageal squamous cancer cells by inactivation of Akt. PMID: 24247637 Ref: gamma-Glutamylcyclotransferase as a novel immunohistochemical biomarker for the malignancy of esophageal squamous tumors. PMID: 24342434 Ref: Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma. PMID: 24366688 Ref: [Expressions and clinical significances of iASPP and caspase-9 in esophageal cancer]. PMID: 24405603 Ref: Combination of adenoviruses expressing melanoma differentiation-associated gene-7 and chemotherapeutic agents produces enhanced cytotoxicity on esophageal carcinoma. PMID: 24434574 Ref: Carcinoma cuniculatum of the esophagus and tongue: report of two cases, including TP53 mutational analysis. PMID: 24470056 Ref: Association between SNPs in P53 binding regions and risk of esophageal squamous cell carcinoma. PMID: 24474449 Ref: Matrine inhibits proliferation and induces apoptosis via BID-mediated mitochondrial pathway in esophageal cancer cells. PMID: 24510386 Ref: Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma. PMID: 24528540 Ref: Expression of bcl-2 and p53 in induction of esophageal cancer cell apoptosis by ECRG2 in combination with cisplatin. PMID: 24606472 Ref: Plk1-targeted therapies in TP53- or RAS-mutated cancer. PMID: 24630986 Ref: Genomic and molecular characterization of esophageal squamous cell carcinoma. PMID: 24686850 Ref: p63 regulates growth of esophageal squamous carcinoma cells via the Akt signaling pathway. PMID: 24718831 Ref: Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer. PMID: 24761876 Ref: PLCE1 suppresses p53 expression in esophageal cancer cells. PMID: 24766303 Ref: p21 rs3176352 G>C and p73 rs1801173 C>T polymorphisms are associated with an increased risk of esophageal cancer in a Chinese population. PMID: 24820515 Ref: The molecular mechanisms of Tanshinone IIA on the apoptosis and arrest of human esophageal carcinoma cells. PMID: 24829906 Ref: Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer. PMID: 24939624 Ref: DADS suppresses human esophageal xenograft tumors through RAF/MEK/ERK and mitochondria-dependent pathways. PMID: 25026173 Ref: Alpha linolenic acid and oleic acid additively down-regulate malignant potential and positively cross-regulate AMPK/S6 axis in OE19 and OE33 esophageal cancer cells. PMID: 25129649 Ref: The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study. PMID: 25135238 Ref: Preoperative chemoradiation therapy in combination with panitumumab for patients with resectable esophageal cancer: the PACT study. PMID: 25195993 Ref: Elevated p53 expression levels correlate with tumor progression and poor prognosis in patients exhibiting esophageal squamous cell carcinoma. PMID: 25202347 Ref: Progression of esophageal dysplasia to cancer. PMID: 25266019 Ref: Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma. PMID: 25280564 Ref: Analysis of TP53 polymorphisms in North Indian sporadic esophageal cancer patients. PMID: 25339039 Ref: TP53 Pro72 allele is enriched in oral tongue cancer and frequently mutated in esophageal cancer in India. PMID: 25436609 Ref: Predicting response to neoadjuvant therapy in esophageal cancer with p53 genotyping: a fortune-teller's crystal ball or a viable prognostic tool? PMID: 25444198 Ref: Tumor suppression by miR-31 in esophageal carcinoma is p21-dependent. PMID: 25568668 |
Ref: A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage. PMID: 25214541 Ref: Sterigmatocystin induces G1 arrest in primary human esophageal epithelial cells but induces G2 arrest in immortalized cells: key mechanistic differences in these two models. PMID: 25294323 Ref: Serum autoantibodies in the early detection of esophageal cancer: a systematic review. PMID: 25433500 Ref: Expression characteristics of FHIT, p53, BRCA2 and MLH1 in families with a history of oesophageal cancer in a region with a high incidence of oesophageal cancer. PMID: 25436004 Ref: Ternary copper(II) complexes with amino acid chains and heterocyclic bases: DNA binding, cytotoxic and cell apoptosis induction properties. PMID: 25555321 Ref: Molecular Characteristics of Basaloid Squamous Cell Carcinoma of the Esophagus: Analysis of KRAS, BRAF, and PIK3CA Mutations and LINE-1 Methylation. PMID: 25691283 Ref: Diagnostic value of multiple tumor markers for patients with esophageal carcinoma. PMID: 25693076 Ref: Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells. PMID: 25733817 Ref: Tumor profiling of gastric and esophageal carcinoma reveal different treatment options. PMID: 25778705 Ref: Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancers. PMID: 25826681 Ref: [Jaridonin induces apoptosis in human esophageal cancer cells by depleting GSH and inducing DNA damage]. PMID: 25877312 Ref: Cytotoxic effects of replication-competent adenoviruses on human esophageal carcinoma are enhanced by forced p53 expression. PMID: 26059686 Ref: The Antitumor Activity of the Novel Compound Jesridonin on Human Esophageal Carcinoma Cells. PMID: 26103161 Ref: Epigenetic Aging Signatures Are Coherently Modified in Cancer. PMID: 26110659 Ref: Association of the p53 Arg72Pro polymorphism with esophageal cancer in Chinese populations: a meta-analysis. PMID: 26345834 Ref: Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma. PMID: 26376349 Ref: Molecular Marker Expression Is Highly Heterogeneous in Esophageal Adenocarcinoma and Does Not Predict a Response to Neoadjuvant Therapy. PMID: 26394876 Ref: Expression of TP53, BCL-2, and VEGFA Genes in Esophagus Carcinoma and its Biological Significance. PMID: 26439224 Ref: Five miRNAs Considered as Molecular Targets for Predicting Esophageal Cancer. PMID: 26498375 Ref: Wide expression of ZEB1 in sarcomatous component of spindle cell carcinoma of the esophagus. PMID: 26515382 Ref: Editorial. PMID: 26520390 Ref: Analysis of the correlation between P53 and Cox-2 expression and prognosis in esophageal cancer. PMID: 26622818 Ref: Effects of orientin and vitexin from Trollius chinensis on the growth and apoptosis of esophageal cancer EC-109 cells. PMID: 26622901 Ref: Neoangiogenesis. Assessment in Esophageal Adenocarcinomas. PMID: 27011493 |
Ref: NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers. PMID: 25906289 Ref: Genetic risk of subsequent esophageal cancer in lymphoma and breast cancer long-term survival patients: a pilot study. PMID: 26054330 Ref: Germline and somatic genetic predictors of pathological response in neoadjuvant settings of rectal and esophageal cancers: systematic review and meta-analysis. PMID: 26122021 Ref: Traditional Chinese medicine targeting apoptotic mechanisms for esophageal cancer therapy. PMID: 26707140 Ref: MDM2 gene amplification in esophageal carcinoma. PMID: 26796597 Ref: Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer. PMID: 26857264 Ref: GADD45A expression is correlated with patient prognosis in esophageal cancer. PMID: 26870203 Ref: Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population. PMID: 26873401 Ref: Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing. PMID: 26900290 Ref: miR-34a inhibits the in vitro cell proliferation and migration in human esophageal cancer. PMID: 26944831 Ref: Costunolide Induces Apoptosis through Generation of ROS and Activation of P53 in Human Esophageal Cancer Eca-109 Cells. PMID: 27078502 Ref: TP53, PIK3CA, FBXW7 and KRAS Mutations in Esophageal Cancer Identified by Targeted Sequencing. PMID: 27107065 Ref: Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer. PMID: 27140836 Ref: RhBMP-2 Activates Hippo Signaling through RASSF1 in Esophageal Cancer Cells. PMID: 27230238 Ref: Prognostic significance of p53 expression in patients with esophageal cancer: a meta-analysis. PMID: 27370310 Ref: Effect of SNX-2112 on proliferation of esophageal cancer cells via regulation of excision repair cross-complementing 1, epidermal growth factor receptor, and p53 expression. PMID: 27420968 Ref: Gene-gene interactions in gastrointestinal cancer susceptibility. PMID: 27588484 Ref: The long non-coding RNA maternally expressed gene 3 activates p53 and is downregulated in esophageal squamous cell cancer. PMID: 27778235 Ref: Hesa-A Effects on Cell Cycle Signaling in Esophageal Carcinoma Cell Line. PMID: 27957293 Ref: [Up-regulation of ErbB3-binding protein 1 inhibits the growth of esophageal carcinoma cells]. PMID: 28004068 |
Ref: Auraptene Attenuates Malignant Properties of Esophageal Stem-Like Cancer Cells. PMID: 27207438 Ref: The Presence of Serum p53 Antibody Predicts the Pathological Tumor Response to Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and Fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma. PMID: 27637603 Ref: The high expression instead of mutation of p53 is predictive of overall survival in patients with esophageal squamous-cell carcinoma: a meta-analysis. PMID: 27882726 Ref: Comprehensive characterization of genes associated with the TP53 signal transduction pathway in various tumors. PMID: 28258440 Ref: Neuroendocrine carcinoma of the esophagus: Clinicopathological and immunohistochemical features of 14 cases. PMID: 28288180 Ref: Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53. PMID: 28341911 Ref: ECRG2 enhances the anti-cancer effects of cisplatin in cisplatin-resistant esophageal cancer cells via upregulation of p53 and downregulation of PCNA. PMID: 28348485 Ref: Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma. PMID: 28365443 Ref: Luteolin inhibits cell proliferation and induces cell apoptosis via down-regulation of mitochondrial membrane potential in esophageal carcinoma cells EC1 and KYSE450. PMID: 28460467 Ref: The Relation of HPV Infection and Expression of p53 and p16 Proteins in Esophageal Squamous Cells Carcinoma. PMID: 28529620 Ref: African-American esophageal squamous cell carcinoma expression profile reveals dysregulation of stress response and detox networks. PMID: 28629367 Ref: Frequent aberrant p53 and Fhit expression in endoscopically resected superficial hypopharyngeal cancer and esophageal cancer. PMID: 28693209 Ref: Expression of methylation-modulated tumor-related genes in endoscopically resected early esophageal squamous neoplasia. PMID: 28693228 Ref: Targeted next-generation sequencing supports epidermoid metaplasia of the esophagus as a precursor to esophageal squamous neoplasia. PMID: 28731047 Ref: Cellular expression, in-vitro and in-vivo confirmation of GAEC1 oncogenic properties in colon cancer. PMID: 28764863 Ref: Cytotoxicity of replication-competent adenoviruses powered by an exogenous regulatory region is not linearly correlated with the viral infectivity/gene expression or with the E1A-activating ability but is associated with the p53 genotypes. PMID: 28874135 Ref: Esophageal Cancer: Genomic and Molecular Characterization, Stem Cell Compartment and Clonal Evolution. PMID: 28930282 Ref: Mutation landscape and intra-tumor heterogeneity of two MANECs of the esophagus revealed by multi-region sequencing. PMID: 29050228 Ref: Inhibition of LSD1 epigenetically attenuates oral cancer growth and metastasis. PMID: 29088714 Ref: Synergistic anticancer effect of combined crocetin and cisplatin on KYSE-150 cells via p53/p21 pathway. PMID: 29093644 Ref: Methylation and expression of RECK, P53 and RUNX genes in patients with esophageal cancer. PMID: 29113164 Ref: Predictive biomarkers for response of esophageal cancer to chemo(radio)therapy: A systematic review and meta-analysis. PMID: 29113666 Ref: Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations. PMID: 29142225 Ref: Phloretin induces apoptosis of human esophageal cancer via a mitochondria-dependent pathway. PMID: 29151915 Ref: Delineation of the HPV11E6 and HPV18E6 Pathways in Initiating Cellular Transformation. PMID: 29164058 Ref: Gene function analysis and underlying mechanism of esophagus cancer based on microarray gene expression profiling. PMID: 29285246 Ref: Low-dose hyperthermia enhances the antitumor effects of chemotherapy in squamous cell carcinoma. PMID: 30052898 |
Ref: Management of Patients With Adenocarcinoma or Squamous Cancer of the Esophagus. PMID: 29037469 Ref: LKB1 inactivation occurs in a subset of esophageal adenocarcinomas and is sufficient to drive tumor cell proliferation. PMID: 29370903 Ref: Expression Level of miR-34a in Tumor Tissue from Patients with Esophageal Squamous Cell Carcinoma. PMID: 29453761 Ref: Potent hydrazone derivatives targeting esophageal cancer cells. PMID: 29475156 Ref: Retention Esophagitis as a Significant Clinical Predictor of Progression to Esophageal Cancer in Achalasia. PMID: 29506341 Ref: POH1 Knockdown Induces Cancer Cell Apoptosis via p53 and Bim. PMID: 29573636 Ref: Molecular Diagnostics in Esophageal and Gastric Neoplasms: 2018 Update. PMID: 29776635 Ref: Prognostic significance of high serum p53 antibody titers in patients with esophageal squamous cell carcinoma. PMID: 29959634 Ref: Immune signatures correlate with L1 retrotransposition in gastrointestinal cancers. PMID: 29970450 Ref: Identification of key genes and pathways for esophageal squamous cell carcinoma by bioinformatics analysis. PMID: 30112053 Ref: PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue. PMID: 30115035 Ref: Effects of zerumbone on proliferation and apoptosis of esophageal cancer cells and on P53 and Bcl-2 expression levels. PMID: 30197671 Ref: Proliferation Potential-Related Protein Promotes the Esophageal Cancer Cell Proliferation, Migration and Suppresses Apoptosis by Mediating the Expression of p53 and Interleukin-17. PMID: 30223275 Ref: Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways. PMID: 30229997 Ref: Clinical significance of interleukin-6 in diagnosis of lung, oral, esophageal, and gall bladder carcinomas. PMID: 30249899 Ref: Foamy Histiocyte-like Esophageal Adenocarcinoma: Unusual Morphology and Diagnostic Pitfalls. PMID: 30275231 Ref: Genomic Characterization of TP53-Wild-Type Esophageal Carcinoma. PMID: 30317074 Ref: Somatic mutant clones colonize the human esophagus with age. PMID: 30337457 Ref: Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patterns. PMID: 30355311 |